Tien Liang Biotech Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 11, 2021
Share
Tien Liang BioTech Co., Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 136.098 million compared to TWD 103.721 million a year ago. Operating income was TWD 9.500 million compared to operating loss of TWD 19.223 million a year ago. Net income was TWD 11.933 million compared to net loss of TWD 17.998 million a year ago. Basic earnings per share from continuing operations was TWD 0.26 compared to basic loss per share from continuing operations of TWD 0.39 a year ago. For the half year, sales was TWD 249.043 million compared to TWD 224.659 million a year ago. Operating loss was TWD 2.683 million compared to TWD 19.398 million a year ago. Net loss was TWD 50,000 compared to TWD 20.076 million a year ago. Basic eps - continuing operations was TWD 0 compared to basic loss per share from continuing operations of TWD 0.44 a year ago.
Tien Liang BioTech Co., Ltd. is a Taiwan-based company principally engaged in the manufacture, wholesale and retail of health food products. The Company is also involved in the import, wholesale and retail of western medicines, as well as the manufacture and sales of traditional Chinese medicines. The Company also provides active pharmaceutical ingredients (APIs), biopharmaceuticals and others. The Company distributes its products in domestic market.